The use of the letter y in pharmaceutical brand names has been steadily increasing over the last two decades. In the five-year […]
A Suffix Like No Other – Navigating the Nonproprietary Naming of Biological Products
The “Nonproprietary Naming of Biological Products” draft guidance was published by the Food and Drug Administration (FDA) in August 2015 […]
Naming Strategies in Pharmaceutical Brand Name Development
One of the questions I am often asked about pharmaceutical brand naming is, “Where do you start?” The public, and […]
Standing Out in the Nonproprietary Naming Arena
When it comes to developing nonproprietary names for pharmaceuticals and biologics, the goal remains consistent: to obtain an appropriate name […]